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Abstract
Objective: To determine variation of hepatic enzymes Vitamin B12 
and D3 levels in cirrhotic patients.
Design: Cross sectional study.
Setting: Cirrhotic patients in Abbasi Shaheed Hospital..
Participants: 250 patients in Abbasi Shaheed Hospital with diag-
nosis of cirrhosis including 141 males and 109 females.
Variable parameters: They include mean ALT, GGT, Alkaline 
phosphatase levels along with Vitamin B12 and D3 levels in blood.
Results: Vitamin B12 levels were 1249.59±487.01pg/ml and 
1422.28±627.75pg/ml in males and females respectively while Vi-
tamin D3 levels were found to be 17.15±10.45 nmol/L in males and 
14.80±14.24 nmol/L in females. Vitamin B12 levels were found to 
be positively correlated with the elevation of ALT and were nega-
tively correlated with elevation of ALT, GGT and Alkaline Phospha-
tase. The ALT levels were 50.0±21.88 in males and 14.80±14.24 in 
females, Alkaline phosphatase to be 311.46±107.98 in males while 
female Alkaline phosphatase were 346.47±101.60. GGT levels to be 
41.70±10.62 in males and 45.01±13.74 in females. 
Conclusion: Cirrhotic patients suffering from severe hepatocellular 
damage have their elevated levels of Vitamin B12 and depressed Vi-
tamin D3 levels in plasma accompanied by a positive association with 
elevated ALT and GGT plasma levels
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Introduction
Vitamin D maintains calcium homeostasis by inte-
racting with the VDR in osteoblasts. It induces the 
expression of plasma membrane protein receptor 
activator of NF-κB ligand (RANKL). The RANK on 
the plasma membrane of pre-osteoclasts binds 
RANKL, which induces the pre-osteoclasts to con-
vert into the mature osteoclast [1, 2, 3]. The ma-
ture osteoclasts are responsible for the release of 
hydrochloric acid and collagenases that dissolve 
bones and results into the releases of calcium and 
phosphorus into the blood circulation. Deficiency of 
Vitamin D is associated with the increased risk of 
colon, breast and prostate cancer [4], cardiovascular 
infections [5, 6] and autoimmune diseases. 25(OH), 
D is used to measure the level of Vitamin D in the 
circulation. It has a half-life of 2 weeks, and it corre-
lates with secondary hyperparathyroidism, rickets, 
and osteomalacia [7]. Vitamin D deficient individuals 
develop abnormalities in glucose metabolism such 
as type 2 diabetes and hypertension, abdominal 
obesity, hyperlipidemia, and insulin intolerance. [8, 
9] There is a strong association of vitamin D3 levels 
and the presence of liver disease. Vitamin D3 increa-
ses the expression of vitamin D receptor (VDR) and 
inhibits the viral replication in cell culture [10]. It is 
also thought to increase the immunity by showing 
antimicrobial effects in both acute and chronic ill-
ness [11, 12]. In chronic liver disease, vitamin D is not 
converted into its active form, resulting in hypovita-
minosis. Research showed that almost 2/3rd of the 
patients with chronic viral hepatitis had abnormal 
levels of vitamin D while 1/3rd had some deficiency.
Vitamin B12 is a water soluble vitamin necessary 
for normal neurological function and formation of 
Red Blood Cells. A deficiency can cause neuronal 
demyelination and axonal degeneration, and if left 
untreated will eventually result in neuronal death. 
Therefore, early diagnosis and timely treatment are 
imperative. [13]
Cirrhosis is defined as the histological develo-
pment of regenerative nodules surrounded by 
fibrous bands in response to chronic liver injury, 
leading to portal hypertension and End Stage Li-
ver Disease (ESLD). [14] Two of the main causes 
of hepatic fibrosis are viral hepatitis and alcohol 
abuse. [15] Globally, Hepatitis B virus is the major 
risk factor for the development of hepatocellular 
Carcinoma (HCC), Cirrhosis, and decompensated 
liver disease. [16] Also, Chronic HCV infection is ac-
companied by variable degrees of hepatic inflam-
mation, damage to the liver and progressive fibro-
sis with an increased risk of progression towards 
Cirrhosis and HCC. [17] It is also seen that Alcohol 
accounts for 80% of all liver cirrhosis cases in dis-
trict general hospitals in the UK. [18] Most of the 
cirrhotic patients die of liver-related causes, which 
may include acute bleeding and infections. [19] A 
study conducted at Alençon Hospital showed that 
22% of deaths in Cirrhotic patients resulted from 
HCC, 12% from gastric bleeding and Liver Failure 
in 21% of cases. In 31% of patients, the cause 
was unrelated to cirrhosis, and in 13% the cause 
was unknown. [20] Cirrhosis is the leading cause 
of death in Asia and it ranks as the tenth most 
common cause of death in US, [21] whereas world-
wide, it is the 12th most common cause. [22] Ac-
cording to W.H.O, the disease accounts for 1.8% 
of all deaths in Europe, causing around 170,000 
deaths per year. [23] Medical treatments that may 
slow down the progression of compensated cirrho-
sis to decompensated cirrhosis are currently being 
developed. [24] Liver Transplantation, however, is 
the only option in a selected subgroup of patients 
with ESLD and HCC. [24]
Materials and methods
This is a cross sectional study conducted in Abba-
si Shaheed Hospital from November 2013 to May 
2014. The sample size of the study is 250. 141 pa-
tients were male while 109 were female patients. 
Those who were diagnosed of Cirrhosis and pre-
viously infected with Hepatitis B and C virus were 
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included while patients taking vitamin supplements 
especially Vitamin B and Vitamin D complex were 
excluded. Diagnosis of the disease was based on cli-
nical signs, laboratory abnormalities and ultrasound 
findings. The analytical parameters determined were 
Vitamin B12, D3, ALT and GGT levels in blood. SPSS 
19 was used for statistical analysis.
Results
The value of R2 is 0.334 which means that the 
model explains 33.4% variation of the dependent 
variable. The P Value of F statistic is <0.001 which 
means that the regression model is a good fit 
of the data.1 unit increase in ALT leads to 10.83 
units increase in Vitamin B12 level, while 1 unit 
increase in GGT leads to 18.80 units increase in 
Vitamin B12 level, and 1 unit increase in Alkaline 
phosphatase leads to 15.02 units increase in Vita-
min B12 level. The p value of ALT, GGT and Alka-
line Phosphatase is less than alpha which means 
that their coefficients are statistically significantly 
different from 0.
The value of R2 is 0.37 which means that the 
model explains 37% variation of the dependent 
variable. The P Value of F statistic is <0.001 which 
means that the regression model is a good fit of 
the data.1 unit increase in GGT leads to 0.043 
unit decrease in Vitamin D3 level while 1 unit 
increase in ALKALINE PHOSPHATASE leads to 
0.043 unit decrease in Vitamin D3 level and 1 
unit increase in ALT leads to 0.42 unit decrease 
in Vitamin D3 level. 
The p value of both Alkaline Phosphatase and 
ALT is less than alpha which means that their 
coefficients are statistically significantly different 
from 0.
Figure 1: Number of patients with hepatitis B & C.
Figure 2: Number of male patients with hepatitis.
Figure 3: Number of female patients with hepatitis. Table 1. Mean values of variables.
Males (mean 
value±s.d)
Females (mean 
value±s.d)
Vitamin b12 1249.59±487.01 1422.28±627.75
Vitamin d3 17.15±10.45 14.80±14.24
Alt 50.0±21.88 50.96±11.20
Gamma gt 41.70±10.62 45.01±13.74
Alkaline 
phosphatase
311.46±107.98 346.47±101.60
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Discussion
Around 170 million people worldwide have chronic 
hepatitis C (CHC) infection [25] causing a substantial 
burden of chronic liver disease globally [26]. The ma-
jority of subjects with CHC are vitamin D deficient 
(<50 nmol/L)27 with 25% having severe deficiency 
(<25 nmol/L) [28]. In those with chronic liver disea-
se the prevalence of vitamin D insufficiency (<75 
nmol/L) is almost universal, with vitamin D deficien-
cy (<50 nmol/L) present in around two-thirds of 
subjects [29]. Various studies suggest that vitamin D 
effects may play a significant role in the pathogene-
sis of chronic liver diseases. [30] Even in the absence 
of cirrhosis, vitamin D deficiency is present in the 
majority of subjects. In those with cirrhosis, the pre-
valence of severe vitamin D deficiency (<25 nmol/L) 
increases with increasing severity of synthetic liver 
dysfunction [31, 32]. Another study also showed 
that vitamin D supplementation improves response 
to antiviral treatment for recurrent hepatitis C. [33] 
Research showed that vitamin D supplementation 
during antiviral treatment of recurrent HCV patients 
result in frequent sustained viral response compared 
to those who were not supplemented.[34]. Harald 
Table 2. Regression analysis of vitamin b12 with other variables.
Model R R Square Adjusted R Square
1 0.578 0.334 0.313
ANOVA
Model df F Sig.
1 3 16.02 0.0001
Coefficients
Model
Unstandardized Coefficients Standardized Coefficients
Sig.
b Beta
SGPT ALT 10.83 0.236 0.007
Gamma GT 18.802 0.48 0.0001
Alkaline Phosphatase 15.02 0.43 0.003
Table 3. Regression analysis of vitamin d3 with other variables.
Model R R Square try to explain more Adjusted R Square try to explain more
1 0.60 0.37 0.35
ANOVA
Model Df F Sig.
1 3 28.58 0.0001
Coefficients
Model
Unstandardized Coefficients Standardized Coefficients
Sig.
B Beta
GGT -0.043 0.053 0.471
Alkaline 
Phosphatase
-0.043 0.334 0.0001
ALT -0.42 0.35 0.0001
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[35] in his study demonstrates the inverse relations-
hip between serum 25 OH vitamin D level and HBV 
viral load rendering increased viral replication to be 
responsible for decreased 25 OH vitamin D levels.
[36] A study by Davide that included only patients 
with chronic hepatitis C, the occurrence of vitamin 
D deficiency (≤20 ng/mL) was observed in Alkaline 
Phosphataseproximately one-half of the patients 
and severe vitamin D deficiency (≤10 ng/mL) in 
Alkaline Phosphataseproximately 16% of them.[36] 
There were limitations to our study, including the 
cross-sectional design which does not possess any 
control group which limits the conclusions about 
directionality; viral load couldn’t be performed due 
to the lack of funds. 
Our findings suggest that cirrhotic patients admit-
ted for complications presented with elevated plasma 
levels of vitamin B12 which were 1249.59±487.01pg/
ml in males and 1422.28±627.75pg/ml in females. 
The results also demonstrate a positive association 
between vitamin B12 and the hepatic enzymes 
where ALT is 50.0±21.88 pg/ml and 50.96±11.20 
pg/ml, and GGT is 41.70±10.62 and 45.01±13.74 
pg/ml in males and females respectively. It means 
that with increasing hepatocellular damage as indi-
cated by elevated hepatic enzymes, serum vitamin 
B12 also tends to increase.[37] Very frequently it has 
been reported that cirrhosis leads to elevated vita-
min B12 levels in serum. Our findings are in accor-
dance with Hubertus et al, who studied male alco-
hol dependent patients with hepatocellular damage 
and found that the serum concentration of vitamin 
B12 was positively correlated with plasma ALT, AST 
and GGT. An explanation may lie in the fact that 
vitamin B12 bound with hepatocytes and storage of 
transcobalamin is disrupted in liver damage causing 
vitamin B12 to leak out of the liver into the circu-
lation to produce severe tissue B12 deficits leading 
to metabolic dysfunction regardless of an elevated 
plasma total vitamin B12. [37]. Certain other studies 
also relate plasma vitamin B12 levels to the develop-
ment of tumors or increased rate of deaths for this 
reason. Goel A et al, in one of their study have also 
regarded vitamin B12 levels as a useful non invasive 
marker to differentiate non-cirrhotic portal hyper-
tension from cryptogenic cirrhosis. [38] Johan F.B. 
Arendt et al, in their study have considered elevated 
vitamin B12 level as a proposal of diagnostic strate-
gy. They unexpectedly got into consideration 8% of 
patients with high plasma vitamin B12 levels among 
patients with its deficiency. After summarizing the 
association between elevated levels and diseases, 
finally they concluded that after ruling out the risk 
of cancer, diseases of liver and kidney can be con-
sidered responsible for the elevation. [39] Areekul S 
et al; also found out that serum vitamin B12 levels in 
patients with infectious hepatitis and cirrhosis were 
higher than that of the normal subjects. [40] Fur-
thermore, Lambert et al; in 1997, found a positive 
association of vitamin B12 with ALT only. [41] Our 
results demonstrate a substantial positive relations-
hip with ALT as well as GGT. 
Conclusion
Our results found elevated vitamin B12 levels in pa-
tients with liver cirrhosis and their positive affiliation 
with increased hepatic enzymes while decrease in 
Vitamin D3 levels associated with cirrhosis.
Abbreviations
ALT: Alanine transaminase.
GGT: Gamma-glutamyl transferase.
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